Recombinant NRF2 antibody (pSer40)
Quick Overview for Recombinant NRF2 antibody (pSer40) (ABIN5557501)
Target
See all NRF2 (NFE2L2) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer40
-
Purpose
- phospho-Nrf2 (Ser40) Recombinant Antibody
-
Cross-Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- A synthesized peptide derived from human Nrf2 around the phosphorylation site of S40
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000), IHC-P(1:200-400), IHC-F(1:100-500), IF(1:50-200), Flow-Cyt(1:50-100), ICC/IF(1:50-100)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- NRF2 (NFE2L2) (Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2))
-
Alternative Name
- Nrf2
-
Background
- Synonyms: NF2L2_HUMAN, Nuclear factor erythroid 2-related factor 2, NFE2L2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2, Nrf 2, Nuclear factor, erythroid derived 2, like 2, NFE2L2, NRF2, NFE2 like bZIP transcription factor 2, HEBP1, IMDDHH,
-
Gene ID
- 4780
-
UniProt
- Q16236
-
Pathways
- ER-Nucleus Signaling, Negative Regulation of intrinsic apoptotic Signaling
Target
-